Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMDR8V9)

Drug Name

ISIS 29202 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting AKT3 messenger RNA (AKT3 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SB-747651A	DM20Q5O	Discovery agent	N.A.	Investigative	[2]
ISIS 29136	DMAMTLR	Discovery agent	N.A.	Investigative	[1]
ISIS 29112	DMECMA6	Discovery agent	N.A.	Investigative	[1]
ISIS 29161	DMPS6OQ	Discovery agent	N.A.	Investigative	[1]
ISIS 29200	DMN1LHI	Discovery agent	N.A.	Investigative	[1]
ISIS 29135	DMGJURC	Discovery agent	N.A.	Investigative	[1]
ISIS 29177	DMSUWVE	Discovery agent	N.A.	Investigative	[1]
ISIS 29160	DM9NB1A	Discovery agent	N.A.	Investigative	[1]
ISIS 29176	DMVLU5J	Discovery agent	N.A.	Investigative	[1]
ISIS 29159	DMLE1IJ	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	US patent application no. 6,187,586, Antisense modulation of AKT-3 expression.
2	Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-o... J Med Chem. 2008 Sep 25;51(18):5663-79.